Manufacture Advanced Medicine, Drug Delivery, Digital Technologies, Business Practice, Standards & Regulation, Supply Chain, Technology and Equipment

Cell and Gene Champions Speak Up

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

Angus Stewart | 11/30/2022 | Opinion

sponsored by Bio-Rad, Eppendorf, Millipore Sigma, OmniaBio, and Thermo Fisher Scientific

This year, our cell and gene supplement takes a close look at the state of the field, and the problems that it is facing. In the main feature, we draw on the expert takes sent to us throughout 2022 by various cell and gene “Champions” – opinion leaders and innovators observing, researching, and trying to commercialize cutting edge cell and gene therapies. Our champions includeBruce Levine (University of Pennsylvania), Chelsea Pratt (Bio-Rad), Dave Seaward (3P innovation), Miguel Forte (BioSenic), and more. Also included in the supplement:

Lentiviral vs adeno-associated – the pros and cons of vector properties
How more efficient manufacturing can help meet rare disease needs
Nineties nostalgia with a major player from gene therapy’s early days
Reaching beyond the lower branches of possible ophthalmic treatments
And more!

Itching to dive in? Download the PDF.

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Manufacture Advanced Medicine, Drug Delivery, Digital Technologies, Business Practice, Standards & Regulation, Supply Chain, Technology and Equipment

Angus Stewart

Associate Editor of The Medicine Maker

Between studying for my English undergrad and Publishing master's degrees I was out in Shanghai, teaching, learning, and getting extremely lost. Now I'm expanding my mind down a rather different rabbit hole: the pharmaceutical industry. Outside of this job I read mountains of fiction and philosophy, and I must say, it's very hard to tell who's sharper: the literati, or the medicine makers.